Chemed earnings were $308.7M for the trailing 12 months ending Mar 31, 2025, with 10.3% growth year over year. The latest CHE earnings report on Mar 31, 2025 announced Q1 2025 earnings of $71.8M, down 20.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CHE reported annual earnings of $302.0M, with 10.8% growth.
CHE past earnings growth
How has CHE's earnings growth performed historically?
On CHE's earnings call on Invalid Date, Chemed (NYSE: CHE) reported Q1 2025 earnings per share (EPS) of $4.91, up 14.19% year over year. Total CHE earnings for the quarter were $71.76 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.30.
As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $308.74 million, a 8.94% increase year over year.
What was CHE's earnings growth in the past year?
As of Chemed's earnings date in Invalid Date, Chemed's earnings has grown 10.28% year over year. This is 5.59 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 15.87%. CHE earnings in the past year totalled $308.74 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.